Exchange Transfusion in Neonates: Procedural Guidelines
Pre-Procedure Preparation
- The American Academy of Pediatrics recommends that exchange transfusion must be performed only by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities, as this is a high-risk procedure with mortality of approximately 3 per 1000 cases and significant morbidity in up to 5% of procedures 1, 2
- Blood products should be available before initiating the procedure, and modified whole blood (red cells and plasma) crossmatched against the mother and compatible with the infant should be used 1, 3
Indications for Exchange Transfusion
- Exchange is indicated when total serum bilirubin rises to threshold levels despite intensive phototherapy during birth hospitalization, according to the American Academy of Pediatrics 3
- Immediate exchange is mandatory for any jaundiced infant manifesting intermediate to advanced acute bilirubin encephalopathy, regardless of whether total serum bilirubin is falling 3
Adjunctive Therapy Before Exchange
- The American Academy of Pediatrics recommends administering intravenous immunoglobulin (0.5-1 g/kg over 2 hours) in isoimmune hemolytic disease if total serum bilirubin is rising despite intensive phototherapy or is within 2-3 mg/dL of the exchange level 1
Procedural Monitoring
- Continuous cardiorespiratory monitoring should be maintained throughout the procedure, and calcium levels should be checked during and after the procedure 1, 4
- Blood glucose should be monitored, as neonates have limited capacity for glycogenolysis and gluconeogenesis 4
Post-Exchange Monitoring
- Total serum bilirubin should be repeated within 2-3 hours if pre-exchange level was ≥25 mg/dL, and intensive phototherapy should be continued after exchange transfusion 1
Common Complications and Management
- Necrotizing enterocolitis is a recognized complication, and blood product-associated risks must always be considered 2, 4, 5
- Thrombosis and vasospasm can occur during the procedure, and trained personnel must be immediately available 2, 5
Critical Safety Considerations
- The procedure should never be performed in an emergency department, as this delays treatment and increases risk, according to the American Academy of Pediatrics 1
- Trained personnel must be immediately available, as the rarity of the procedure in modern practice may affect complication rates 2, 5
Guidelines for Blood Selection in Neonatal Double‑Volume Exchange Transfusion
Blood Product Selection Principles
- The American Academy of Pediatrics recommends that blood used for exchange transfusion be modified whole blood (red cells + plasma) that is cross‑matched to the mother and compatible with the infant【6】.
Red Blood Cell Component
- Group O red blood cells, preferably O‑negative, should be used for the red‑cell component of the exchange because they lack A and B antigens and therefore avoid reactions with any maternal anti‑A or anti‑B antibodies that may be present in the neonate’s circulation【6】.
- The use of O‑negative RBCs is critical when the mother is AB⁺, since passively transferred maternal antibodies can circulate in the newborn, and the infant’s immune system is still immature【7】【8】.
- Do not use the infant’s own blood type (e.g., A⁺) for the red‑cell component, even though it matches the baby’s type; O‑negative RBCs provide the highest safety margin against reactions with circulating maternal antibodies【6】.
Plasma Component
- AB plasma (or plasma compatible with both the infant and the mother) should be used for the plasma component because it lacks anti‑A and anti‑B antibodies and will not react against the infant’s A antigens【6】.
- AB plasma is considered the universal donor plasma and is therefore the preferred choice for neonatal exchange transfusion【6】.
- When AB plasma is unavailable, type‑A plasma can be used as it is compatible with an A⁺ infant【6】.
Clinical Rationale
- Trans‑placental transfer of maternal antibodies creates a unique compatibility profile in neonates that differs from older children and adults, necessitating the use of O‑negative RBCs and AB plasma【7】【8】.
- Because neonates are immunologically naïve, maternal antibodies may remain circulating for several days after birth, influencing the selection of blood components for exchange transfusion【7】.
- Even though an AB⁺ mother is a universal recipient and does not produce naturally occurring anti‑A or anti‑B antibodies, the standard protocol still recommends O‑negative RBCs to maximize safety【6】.